About Us Telehealth Patients Providers Clinics Careers Appointments RESEARCH California Institute of Renal Research The California Institute of Renal Research is a strategic Study Management Organization that collaborates early on cutting edge-therapeutics with Pharma and Device sponsors. Our important role in executing clinical trials that Pioneer New Therapeutics is manifest through Pride in Our GCP Processes and having Passion for the Patients we serve. Principal Investigators George Fadda, MD, FACP • La Mesa, CA Jill Meyer, MD | Adam Horeish, MD • Chula Vista, CA Arman Faravardeh, MD, FACP, FASN, FAST | Kristian Brown, MD, PhD, FACP • Frost (Transplant & Vascular Access) Ramin Berenji, MD, FACP, FASN • El Centro, CA Osman Khawar, MD, MPH | Joseph Hebreo, MD • Escondido, CA Dylan Steer, MD | Mark Boiskin, MD • Kearney Mesa, CA Selection of Current Studies Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RGL4326 Administered via Subcutaneous Injection to Patients with Autosomal Dominant Polycystic Kidney Disease 1B Phase 2 Multicenter, Randomized, Double-Blind, Placebo Controlled, Multiple Dosing Interval, 3-Period Study of the Safety, Tolerability and Effectiveness of adoptively Transferred Viralym-M Multivirus- 2 Specific T Cells in Kidney Transplant Recipients With Either High or Low Levels of BK Viremia 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of AZD5718 in Participants with Proteinuric CKD 2B Study to Compare the Efficacy and Safety of Humacyte’s Human Acellular Vessel with that of an Autologous Arteriovenous Fistula in Subjects with ESRD 3 A Multicenter, randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients 3 Randomized, Double-Blind, Placebo-Controlled Study to assess the Efficacy and Safety of SNF472 When added to Background Care for the Treatment of Calciphylaxis 3 A Double-Blind Randomized Placebo-Controlled Parallel Design Multicenter Phase IIIb Study of the effect of Sodium Zirconium Cyclosilicate (SZC) on Serium Potassium and Serium Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with CKD 3B Industry Alliance Platform to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients 4 A Single-Arm Study to Evaluate the Effectiveness of EndoAVF in a Pre-Dialysis Population 4 Contact Us – Quick Links Patients Research Leadership Business Development Trial Operations Contact Info 4225 Executive Square Suite 450 La Jolla, CA 92037 Phone (858) 810-8000 Email info@bnmg.org Social Media Visit Our Sister Sites Balboa United Camino Renal Care General COVID-19 Info COVID-19 Resources Testing Locations Vaccine Facts Vaccine Phases & Tiers COVID-19 Info by County Imperial County Orange County San Diego County Quick Links Home About The BNMG Blog Join Our Team Locations New Patients Research Resources Services Copyright © 2021 Balboa Nephrology Medical Group Powered by Balboa Nephrology Medical Group Book an Appointment Translate »